These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22683222)

  • 1. Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.
    Long DD; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Goldblum AA; Humphrey PP; Marquess DG; Shaw JP; Smith JA; Derek Turner S; Vickery RG
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4849-53. PubMed ID: 22683222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.
    Long DD; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Genov D; Goldblum AA; Humphrey PP; Jiang L; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6048-52. PubMed ID: 22959244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.
    McKinnell RM; Armstrong SR; Beattie DT; Fatheree PR; Long DD; Marquess DG; Shaw JP; Vickery RG
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4210-5. PubMed ID: 23756062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.
    McKinnell RM; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Goldblum A; Humphrey PP; Long DD; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
    J Med Chem; 2009 Sep; 52(17):5330-43. PubMed ID: 19663444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.
    Shen F; Smith JA; Chang R; Bourdet DL; Tsuruda PR; Obedencio GP; Beattie DT
    Neuropharmacology; 2011; 61(1-2):69-79. PubMed ID: 21392515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
    Brudeli B; Andressen KW; Moltzau LR; Nilsen NO; Levy FO; Klaveness J
    Bioorg Med Chem; 2013 Nov; 21(22):7134-45. PubMed ID: 24113240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach.
    Meng T; Wang J; Peng H; Fang G; Li M; Xiong B; Xie X; Zhang Y; Wang X; Shen J
    Eur J Med Chem; 2010 Mar; 45(3):1133-9. PubMed ID: 20047779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.
    Becker OM; Dhanoa DS; Marantz Y; Chen D; Shacham S; Cheruku S; Heifetz A; Mohanty P; Fichman M; Sharadendu A; Nudelman R; Kauffman M; Noiman S
    J Med Chem; 2006 Jun; 49(11):3116-35. PubMed ID: 16722631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.
    Hong Q; Bakshi RK; Palucki BL; Park MK; Ye Z; He S; Pollard PG; Sebhat IK; Liu J; Guo L; Cashen DE; Martin WJ; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; MacIntyre DE; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2330-4. PubMed ID: 21439820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists.
    Kiyoi T; Adam JM; Clark JK; Davies K; Easson AM; Edwards D; Feilden H; Fields R; Francis S; Jeremiah F; McArthur D; Morrison AJ; Prosser A; Ratcliffe PD; Schulz J; Wishart G; Baker J; Campbell R; Cottney JE; Deehan M; Epemolu O; Evans L
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1748-53. PubMed ID: 21316962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's disease.
    Brodney MA; Johnson DE; Sawant-Basak A; Coffman KJ; Drummond EM; Hudson EL; Fisher KE; Noguchi H; Waizumi N; McDowell LL; Papanikolaou A; Pettersen BA; Schmidt AW; Tseng E; Stutzman-Engwall K; Rubitski DM; Vanase-Frawley MA; Grimwood S
    J Med Chem; 2012 Nov; 55(21):9240-54. PubMed ID: 22974325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.
    Asagarasu A; Matsui T; Hayashi H; Tamaoki S; Yamauchi Y; Minato K; Sato M
    J Med Chem; 2010 Nov; 53(21):7549-63. PubMed ID: 20931963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomnia.
    Xiong Y; Ullman B; Choi JS; Cherrier M; Strah-Pleynet S; Decaire M; Dosa PI; Feichtinger K; Teegarden BR; Frazer JM; Yoon WH; Shan Y; Whelan K; Hauser EK; Grottick AJ; Semple G; Al-Shamma H
    J Med Chem; 2010 Aug; 53(15):5696-706. PubMed ID: 20684606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.
    Park JS; Im W; Choi S; Park SJ; Jung JM; Baek KS; Son HP; Sharma S; Kim IS; Jung YH
    Eur J Med Chem; 2016 Feb; 109():75-88. PubMed ID: 26761776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
    Chambers MS; Street LJ; Goodacre S; Hobbs SC; Hunt P; Jelley RA; Matassa VG; Reeve AJ; Sternfeld F; Beer MS; Stanton JA; Rathbone D; Watt AP; MacLeod AM
    J Med Chem; 1999 Feb; 42(4):691-705. PubMed ID: 10052976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.
    Castriconi F; Paolino M; Giuliani G; Anzini M; Campiani G; Mennuni L; Sabatini C; Lanza M; Caselli G; De Rienzo F; Menziani MC; Sbraccia M; Molinari P; Costa T; Cappelli A
    Eur J Med Chem; 2014 Jul; 82():36-46. PubMed ID: 24871995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.